Science & Enterprise subscription

Follow us on Twitter

  • Evidence collected from electronic neuro-stimulation devices shows for most people the wearable systems relieve mig… https://t.co/2RsxkVvoUA
    about 18 hours ago
  • New post on Science and Enterprise: Wearable Device Shown to Relieve Migraine Pain https://t.co/mKP8iAVKCm #Science #Business
    about 18 hours ago
  • Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editi… https://t.co/uG1FkdMzJv
    about 20 hours ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy https://t.co/3tixJDiac0 #Science #Business
    about 21 hours ago
  • First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy… https://t.co/Cgw8tTAAKY
    about 2 days ago

Please share Science & Enterprise

Digital Sedation Company Raises $11.8M in Early Funds

Sedakit

A Belgian company creating virtual reality systems for sedation in surgery and invasive procedures is raising €10 million in its first venture funding round. . . . → Read More: Digital Sedation Company Raises $11.8M in Early Funds

Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

Syrine ingloved hand

In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines. . . . → Read More: Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines

Small Antibody Shown to Block Covid-19 Infection

Alpaca

Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism. . . . → Read More: Small Antibody Shown to Block Covid-19 Infection

Brain Signal Synchronization Device in Development

Brain activity graphic

An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain. . . . → Read More: Brain Signal Synchronization Device in Development

Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial

Syringes

Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S. . . . → Read More: Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial

Food Allergy Biotech Acquired for $2.6B

Palforzia capsules

Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion. . . . → Read More: Food Allergy Biotech Acquired for $2.6B

Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Lab mouse

Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells. . . . → Read More: Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy

Sanofi Acquires Immune Disease Biotech in $3.7B Deal

Human B-cell

A developer of small-molecule therapies for autoimmune diseases, including multiple sclerosis, and other immune disorders is being acquired by Sanofi. . . . → Read More: Sanofi Acquires Immune Disease Biotech in $3.7B Deal

Trial Testing Rare Disease Drug for Covid-19 Pneumonia

Human lungs illustration

A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections. . . . → Read More: Trial Testing Rare Disease Drug for Covid-19 Pneumonia

Infographic – Mental Health Effects of Pandemic

Covid-19 and mental health chart

Physical symptoms experienced by people with Covid-19 infections are well documented over the past few months, but the psychological toll is also beginning to get attention. . . . → Read More: Infographic – Mental Health Effects of Pandemic